Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacoepidemiological Study on the Risk of Bleeding in New Users of Low-dose Aspirin (ASA) in The Health Improvement Network (THIN), UK

NCT02550717 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02550717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02550717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacoepidemiological Study on the Risk of Bleeding in New Users of Low-dose Aspirin (ASA) in The Health Improvement Network (THIN), UK
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
September 1, 2015
Completion date
March 31, 2017
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, ischemic heart disease, secondary prevention, stroke